Skip to main content

. 1982 Apr;45(4):625–645. doi: 10.1038/bjc.1982.102

Combined modality therapy: clinical and laboratory aspects.

PMCID: PMC2010974 PMID: 7073954

625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Birch J. M., Swindell R., Marsden H. B., Morris Jones P. H. Childhood leukaemia in North West England 1954-1977: epidemiology, incidence and survival. Br J Cancer. 1981 Mar;43(3):324–329. doi: 10.1038/bjc.1981.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
Brandt L., Nilsson P. G., Mitelman F. Trends in incidence of acute leukaemia. Lancet. 1979 Nov 17;2(8151):1069–1069. [PubMed] [Google Scholar]
Clemmesen J. Cluster of myeloid leukaemia. Lancet. 1979 Dec 8;2(8154):1238–1239. doi: 10.1016/s0140-6736(79)92353-5. [DOI] [PubMed] [Google Scholar]
Clemmesen J. Statistical studies in the aetiology of malignant neoplasms. 3. Acta Pathol Microbiol Scand Suppl. 1969;209(Suppl):1+–1+. [PubMed] [Google Scholar]
Ericsson J. L., Karnström L., Mattsson B. Childhood cancer in Sweden, 1958-1974. I. Incidence and mortality. Acta Paediatr Scand. 1978 Jul;67(4):425–432. doi: 10.1111/j.1651-2227.1978.tb16349.x. [DOI] [PubMed] [Google Scholar]
Freedman L., Dent N. A., Hunt C., Payne P. M., Smith P. G. Letter: Incidence of childhood leukaemia. Lancet. 1974 May 25;1(7865):1059–1059. doi: 10.1016/s0140-6736(74)90466-8. [DOI] [PubMed] [Google Scholar]
Gapski G. R., Whiteley J. M., Rader J. I., Cramer P. L., Henderson G. B., Neef V., Huennekens F. M. Synthesis of a fluorescent derivative of amethopterin,. J Med Chem. 1975 May;18(5):526–528. doi: 10.1021/jm00239a020. [DOI] [PubMed] [Google Scholar]
HEWITT D. Some features of leukaemia mortality. Br J Prev Soc Med. 1955 Apr;9(2):81–88. doi: 10.1136/jech.9.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kemp I. W., Stein G. J., Heasman M. A. Myeloid leukaemia in Scotland. Lancet. 1980 Oct 4;2(8197):732–734. doi: 10.1016/s0140-6736(80)91948-0. [DOI] [PubMed] [Google Scholar]
Leck I., Benn R. T., Smith A. Changes in myeloid leukaemia incidence? Lancet. 1980 Oct 4;2(8197):749–750. doi: 10.1016/s0140-6736(80)91973-x. [DOI] [PubMed] [Google Scholar]
Millar J. L., McElwain T. J. Combinations of cytotoxic agents that have less than expected toxicity on normal tissues in mice. Antibiot Chemother (1971) 1978;23:271–282. doi: 10.1159/000401490. [DOI] [PubMed] [Google Scholar]
Schlom J., Spiegelman S. Simultaneous detection of reverse transcriptase and high molecular weight RNA unique to oncogenic RNA viruses. Science. 1971 Nov 19;174(4011):840–843. doi: 10.1126/science.174.4011.840. [DOI] [PubMed] [Google Scholar]
Stewart A. Aetiology of Childhood Malignancies. Br Med J. 1961 Feb 18;1(5224):452–460. doi: 10.1136/bmj.1.5224.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
Suit H. D., Maimonis P., Rich T. A., Sedlacek R. S. Anaesthesia and efficacy of hyperbaric oxygen in radiation therapy. Br J Radiol. 1979 Mar;52(615):244–244. doi: 10.1259/0007-1285-52-615-244. [DOI] [PubMed] [Google Scholar]
WEAVER G., LANDAU B. R. CONTRIBUTION OF THE PENTOSE CYCLE TO GLUCOSE METABOLISM BY ADRENAL CORTEX IN VITRO. Endocrinology. 1963 Nov;73:640–646. doi: 10.1210/endo-73-5-640. [DOI] [PubMed] [Google Scholar]
Waterhouse J. A., Powell J. Letter: Incidence of childhood leukaemia. Lancet. 1973 Dec 1;2(7840):1274–1274. doi: 10.1016/s0140-6736(73)91025-8. [DOI] [PubMed] [Google Scholar]
Yuhas J. M. Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine. Cancer Treat Rep. 1979 Jun;63(6):971–976. [PubMed] [Google Scholar]

ACTIONS

RESOURCES